Effect of PNF-Based Upper Extremity Strengthening With Core Stabilization on Fitness in Amputee Football Players

March 26, 2026 updated by: Mert İlhan, Uskudar University

The Effect of Proprioceptive Neuromuscular Facilitation Based Upper Extremity Strengthening Exercises Combined With Core Stabilization Training on Physical Fitness Parameters in Amputee Football Players

Amputee football (AF) is a disability-specific football in which amputees can participate. This study aims to determine the effect of PNF-based upper extremity strengthening exercises combined with core stabilization exercises on physical fitness parameters in amputee football players. In the study, amputee soccer players will be randomly divided into two groups training and control groups. In addition to the standard training programs in the off-season, the amputee athletes in the training group will receive PNF-based upper extremity strengthening training combined with core stabilization training by the same physiotherapist 3 days a week for 8 weeks. The amputee football players in the control group will be given upper extremity strengthening training with free weights in addition to core stabilization training 3 days a week for 8 weeks. The physical and demographic characteristics of the cases who signed the consent form will be recorded. Initial evaluations will be made before the start of the exercise training program and secondary evaluations will be made at the end of 8 weeks. Detailed information about the participants will be obtained with the Descriptive Characteristics Information Form. Single Leg Balance Test, Berg Balance Scale and Activity Specific Balance Confidence Scale will be used to obtain information about postural control and balance strategies of the participants. Pressure Feedback Unit will be used to measure the stabilization capacity of deep spinal muscles. Trunk muscle endurance tests developed by McGill will be used to assess the level of core stability. Isokinetic muscle strength of the upper extremity muscles will be measured with the ISOMED 2000 (2017-Germany) device. Hand grip strength will be measured with Jamar Hand Dynanometer. Closed Kinetic Ring Upper Extremity Test will be used to measure the strength, anaerobic power, and closed kinetic chain stability of the upper extremity. The Distance Triple Hop Test will be used to assess the strength, speed, balance, and control ability of a lower extremity with special emphasis on the distance traveled by the lower extremity. Sprint Test will be used to measure the running performance of amputee soccer players. The data will then be analyzed and interpreted with appropriate statistical methods.

Study Overview

Status

Active, not recruiting

Detailed Description

Amputee football (AF) is a disability-specific football in which amputees can participate. Optimum flexibility, strength, endurance, speed, and agility are required to perform adequately in amputee football. However, amputee soccer requires intense strength and stability requirements on the upper extremities and trunk, especially due to the use of crutches. The aim of this study is to determine the effect of PNF-based upper extremity strengthening exercises combined with core stabilization exercises on physical fitness parameters in amputee football players. In the study, amputee soccer players will be randomly divided into two groups training and control groups. In addition to the standard training programs in the off-season, the amputee athletes in the training group will receive PNF-based upper extremity strengthening training combined with core stabilization training by the same physiotherapist 3 days a week for 8 weeks. The amputee football players in the control group will be given upper extremity strengthening training with free weights in addition to core stabilization training 3 days a week for 8 weeks. The physical and demographic characteristics of the cases who signed the consent form will be recorded. Initial evaluations will be made before the start of the exercise training program and secondary evaluations will be made at the end of 8 weeks. Detailed information about the participants will be obtained with the Descriptive Characteristics Information Form. Single Leg Balance Test, Berg Balance Scale, and Activity Specific Balance Confidence Scale will be used to obtain information about postural control and balance strategies of the participants. Pressure Feedback Unit will be used to measure the stabilization capacity of deep spinal muscles. Trunk muscle endurance tests developed by McGill will be used to assess the level of core stability. Isokinetic muscle strength of the upper extremity muscles will be measured with the ISOMED 2000 (2017-Germany) device. Hand grip strength will be measured with Jamar Hand Dynanometer. Closed Kinetic Ring Upper Extremity Test will be used to measure the strength, anaerobic power, and closed kinetic chain stability of the upper extremity. The Distance Triple Hop Test will be used to assess the strength, speed, balance, and control ability of a lower extremity with special emphasis on the distance traveled by the lower extremity. Sprint Test will be used to measure the running performance of amputee soccer players. The data will then be analyzed and interpreted with appropriate statistical methods.

Study Type

Interventional

Enrollment (Estimated)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey (Türkiye)
        • Uskudar University Physiotherapy and Rehabilitation Application and Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • At least one year of experience in playing amputee soccer.
  • Transtibial, knee disarticulation, or transfemoral level amputation.

Exclusion Criteria:

  • Presence of upper extremity amputation.
  • Bilateral lower extremity amputation.
  • Underwent upper or lower extremity surgery within the last 6 months.
  • Neurological disease, vestibular or visual problems.
  • Use of medication affecting the central nervous system.
  • Any pathology that may affect motor performance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training Group
In addition to the standard training programs in the off-season period; PNF-based upper extremity strengthening training will be performed 3 days a week for 8 weeks in addition to core stabilization training.
Proprioceptive Neuromuscular Facilitation(PNF) based upper extremity strengthening exercises to increase upper extremity muscle strength will be applied to the participants in the training group 3 days a week for 8 weeks. PNF-based upper extremity strengthening exercises will be performed with an elastic resistive band using bilateral symmetrical PNF patterns of "Flexion-Adduction-External Rotation-Extension-Abduction-Internal Rotation", "Flexion-Abduction-External Rotation-Extension-Adduction-Internal Rotation" on two different diagonals while individuals are in a sitting position in a supported chair. Core Stabilization Training will be continued for 8 weeks by increasing the difficulty and intensity of the exercises with limb movements and floor modifications after the amputee football players are taught how to find their neutral spine and how to maintain the position.
Experimental: Control Group
The amputee football players in the control group will be trained 3 days a week for 8 weeks with isotonic strengthening exercises of the upper extremity muscles with free weights and core stabilization training.
The control group will be trained with isotonic strengthening exercises of upper extremity muscles with free weights and core stabilization training 3 days a week for 8 weeks. Isotonic exercises involve muscle contraction with movement, where the muscle length changes while maintaining constant tension. Free weights such as dumbells will be used in the implementation of the exercises. 1 Repetition Maximum (1RM) method will be used to determine the progression of the exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isokinetic Upper Extremity Muscle Strength
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
The strength of the shoulder, elbow, and wrist muscles will be assessed using an isokinetic dynamometer (ISOMED 2000). Measurements will be taken at angular velocities of 60°/s and 180°/s in concentric-concentric mode for abduction-adduction and internal-external rotation movements. The peak torque values will be recorded.
Baseline (pre-intervention) and at 8 weeks (post-intervention).
Core Muscle Strength
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
Core muscle strength will be measured using the Stabilizer Pressure Biofeedback Unit (Chattanoga Group,2005). The device will be used to assess the ability of participants to maintain a neutral spine position during various core stabilization exercises.
Baseline (pre-intervention) and at 8 weeks (post-intervention).
Sprint Performance
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
Sprint performance will be assessed by recording the time it takes for participants to complete 10m, 20m, and 30m sprints using crutches. Two trials will be conducted, and the best times will be recorded.
Baseline (pre-intervention) and at 8 weeks (post-intervention).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postural Stability
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
The Berg Balance Scale will be used to assess the overall postural stability and balance of the participants. This test consists of 14 tasks that measure a range of balance activities, each scored from 0 to 4. Higher scores indicate better balance and stability.
Baseline (pre-intervention) and at 8 weeks (post-intervention).
Balance Confidence
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
Activities-Specific Balance Confidence Scale (ABC) will assess the participants' confidence in maintaining balance during various activities. It includes 16 items scored from 0% (no confidence) to 100% (full confidence).
Baseline (pre-intervention) and at 8 weeks (post-intervention).
Static Balance Assessment
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
The Single Leg Stance Test will be used to assess static balance and postural control. Participants will be asked to stand on one leg with their arms either on their hips or crossed over their shoulders. The time (in seconds) they can maintain balance without losing posture will be recorded. The best of three trials will be used for analysis.
Baseline (pre-intervention) and at 8 weeks (post-intervention).
Upper Extremity Endurance and Stability
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
Closed Kinetic Chain Upper Extremity Stability Test will be used to assess upper extremity stability and endurance. Participants will perform in push-up position, touching two lines placed 0.9 meters apart as many times as possible within 15 seconds. The total number of touches will be recorded.
Baseline (pre-intervention) and at 8 weeks (post-intervention).
Grip Strength Assessment
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
Grip strength will be measured using a Jamar hand dynamometer according to the American Society of Hand Therapists (ASHT) protocol. Participants will perform three trials with their dominant hand, and the average value will be recorded.
Baseline (pre-intervention) and at 8 weeks (post-intervention).
Athletic Performance (Triple Hop Distance Test)
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
The Triple Hop Distance Test will be used to assess the explosive power, balance, and control of the lower extremity. Participants will be asked to hop as far as possible on one leg, three consecutive times without losing balance. The distance from the starting point to the final landing point will be measured and recorded.
Baseline (pre-intervention) and at 8 weeks (post-intervention).
Core Stability Level
Time Frame: Baseline (pre-intervention) and at 8 weeks (post-intervention).
Core stability will be evaluated using the McGill core tests, which include the Sorensen test, trunk flexion test, and side bridge tests. These tests measure the endurance of the core muscles by recording the time (in seconds) participants can maintain specific postures.
Baseline (pre-intervention) and at 8 weeks (post-intervention).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Fatih Erbahçeci, PhD., Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2024

Primary Completion (Actual)

June 1, 2025

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

August 13, 2024

First Submitted That Met QC Criteria

August 13, 2024

First Posted (Actual)

August 15, 2024

Study Record Updates

Last Update Posted (Actual)

April 1, 2026

Last Update Submitted That Met QC Criteria

March 26, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe